Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Receivables - Net (2017 - 2021)

Historic Receivables - Net for Protagonist Therapeutics (PTGX) over the last 5 years, with Q1 2021 value amounting to $100000.0.

  • Protagonist Therapeutics' Receivables - Net fell 6666.67% to $100000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $100000.0, marking a year-over-year decrease of 6666.67%. This contributed to the annual value of $300000.0 for FY2019, which is 291.26% down from last year.
  • According to the latest figures from Q1 2021, Protagonist Therapeutics' Receivables - Net is $100000.0, which was down 6666.67% from $100000.0 recorded in Q2 2020.
  • In the past 5 years, Protagonist Therapeutics' Receivables - Net registered a high of $700000.0 during Q3 2019, and its lowest value of $19000.0 during Q2 2017.
  • In the last 5 years, Protagonist Therapeutics' Receivables - Net had a median value of $103000.0 in 2017 and averaged $199266.7.
  • Its Receivables - Net has fluctuated over the past 5 years, first surged by 45937.5% in 2019, then plummeted by 7206.7% in 2020.
  • Protagonist Therapeutics' Receivables - Net (Quarter) stood at $58000.0 in 2017, then skyrocketed by 432.76% to $309000.0 in 2018, then dropped by 2.91% to $300000.0 in 2019, then tumbled by 66.67% to $100000.0 in 2020, then changed by 0.0% to $100000.0 in 2021.
  • Its last three reported values are $100000.0 in Q1 2021, $100000.0 for Q2 2020, and $300000.0 during Q1 2020.